{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:21:01Z","timestamp":1767046861276},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>The objective of this study was to investigate the pattern and the oncologic impact of local recurrence after surgical resection of pancreatic cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From July 1992 to December 2016, 388 patients who underwent curative-intent surgery for pancreatic ductal adenocarcinoma were retrospectively reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>At a median follow-up of 29.0 months, 286 (73.7%) of the 367 patients experienced recurrence, and the 5-year overall survival rate was 31.3%. The first recurrence pattern was local in 83 patients (22.0%), systemic in 152 patients (40.2%), and locosystemic in 51 patients (13.5%). There was no difference in overall survival between the patients who had either local or systemic recurrence (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.05). Remnant pancreas, common hepatic artery, celiac trunk, and para-aortic area were the common local recurrence sites in both head and body\/tail cancer. However, the superior mesenteric artery (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.050) and portal vein (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001) were more frequent local recurrence sites for a head tumor, and the surgical bed was a common recurrence site for body\/tail tumor (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our study shows the importance of local recurrence on overall survival and that preferred sites of local recurrence according to tumor location are predictable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000001679","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T06:00:09Z","timestamp":1603864809000},"page":"1290-1296","source":"Crossref","is-referenced-by-count":7,"title":["Oncologic Impact of Local Recurrence in Resected Pancreatic Cancer and Topographic Preference in Local Recurrence Patterns According to Tumor Location"],"prefix":"10.1097","volume":"49","author":[{"given":"Sung Hoon","family":"Choi","sequence":"first","affiliation":[{"name":"Division of Hepatobiliary and Pancreas, Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Yan","family":"Kim","sequence":"additional","affiliation":[{"name":"Medical Statistics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Kyoung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"bib1-20230822","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrgastro.2009.177","article-title":"Epidemiology of pancreatic cancer: an overview","volume":"6","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"bib2-20230822","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4143\/crt.2018.142","article-title":"Prediction of cancer incidence and mortality in Korea, 2018","volume":"50","year":"2018","journal-title":"Cancer Res Treat"},{"key":"bib3-20230822","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R","article-title":"The National Cancer Data Base report on pancreatic cancer","volume":"76","year":"1995","journal-title":"Cancer"},{"key":"bib4-20230822","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.sla.0000259391.84304.2b","article-title":"Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma","volume":"246","year":"2007","journal-title":"Ann Surg"},{"key":"bib5-20230822","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejso.2008.12.006","article-title":"Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma","volume":"35","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"bib6-20230822","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"bib7-20230822","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"bib8-20230822","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.surg.2005.06.044","article-title":"A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma","volume":"138","year":"2005","journal-title":"Surgery"},{"key":"bib9-20230822","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jhbp.465","article-title":"Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: a multicenter prospective randomized controlled study","volume":"24","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"bib10-20230822","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00534-011-0466-6","article-title":"Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial","volume":"19","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"bib11-20230822","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00000658-199810000-00007","article-title":"Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group","volume":"228","year":"1998","journal-title":"Ann Surg"},{"key":"bib12-20230822","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000658-199905000-00003","article-title":"Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome","volume":"229","year":"1999","journal-title":"Ann Surg"},{"key":"bib13-20230822","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.bjc.6604838","article-title":"Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials","volume":"100","year":"2009","journal-title":"Br J Cancer"},{"key":"bib14-20230822","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial","volume":"297","year":"2007","journal-title":"JAMA"},{"key":"bib15-20230822","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605256","article-title":"A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer","volume":"101","year":"2009","journal-title":"Br J Cancer"},{"key":"bib16-20230822","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.surg.2013.06.050","article-title":"Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?","volume":"155","year":"2014","journal-title":"Surgery"},{"key":"bib17-20230822","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.surg.2018.05.050","article-title":"Resection for recurrent pancreatic cancer in the remnant pancreas after pancreatectomy is clinically promising: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery","volume":"164","year":"2018","journal-title":"Surgery"},{"key":"bib18-20230822","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1245\/s10434-014-4192-6","article-title":"Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer","volume":"22","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"bib19-20230822","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1186\/s12885-018-4663-4","article-title":"Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy \u2014 a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)","volume":"18","year":"2018","journal-title":"BMC Cancer"},{"key":"bib20-20230822","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1245\/s10434-017-5810-x","article-title":"Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for patients with pancreatic adenocarcinoma: a Surveillance, Epidemiology and End Results (SEER) analysis","volume":"24","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"bib21-20230822","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11605-008-0762-x","article-title":"Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio","volume":"13","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"bib22-20230822","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00432-012-1165-7","article-title":"Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy","volume":"138","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"bib23-20230822","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1245\/s10434-009-0743-7","article-title":"Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study","volume":"17","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"bib24-20230822","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jamcollsurg.2015.12.031","article-title":"Adjuvant therapy in pancreas cancer: does it influence patterns of recurrence?","volume":"222","year":"2016","journal-title":"J Am Coll Surg"},{"key":"bib25-20230822","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.ejso.2019.04.007","article-title":"Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer","volume":"45","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"bib26-20230822","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.seminoncol.2018.12.002","article-title":"Neoadjuvant treatment for pancreatic cancer","volume":"46","year":"2019","journal-title":"Semin Oncol"},{"key":"bib27-20230822","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/0192623316645860","article-title":"Preclinical safety evaluation in rats of a polymeric matrix containing an siRNA drug used as a local and prolonged delivery system for pancreatic cancer therapy","volume":"44","year":"2016","journal-title":"Toxicol Pathol"},{"key":"bib28-20230822","doi-asserted-by":"crossref","first-page":"12381","DOI":"10.1038\/s41598-017-12670-3","article-title":"Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"bib29-20230822","doi-asserted-by":"crossref","first-page":"40140","DOI":"10.18632\/oncotarget.17370","article-title":"Locally-applied 5-fluorouracil-loaded slow-release patch prevents pancreatic cancer growth in an orthotopic mouse model","volume":"8","year":"2017","journal-title":"Oncotarget"},{"issue":"Pt 4","key":"bib30-20230822","first-page":"527","article-title":"The \u2018perineural epithelium\u2019, a metabolically active, continuous, protoplasmic cell barrier surrounding peripheral nerve fasciculi","volume":"96","year":"1962","journal-title":"J Anat"},{"key":"bib31-20230822","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1096-9098(199707)65:3<164::AID-JSO4>3.0.CO;2-4","article-title":"Perineural invasion by ductal adenocarcinoma of the pancreas","volume":"65","year":"1997","journal-title":"J Surg Oncol"},{"key":"bib32-20230822","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.surg.2013.04.015","article-title":"Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer","volume":"154","year":"2013","journal-title":"Surgery"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000001679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:45:35Z","timestamp":1692704735000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000001679","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"value":"1536-4828","type":"electronic"},{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}